Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tate Thigpen

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cancer Journal (Sudbury, Mass.)|December 24, 2003
The role of chemotherapy in the management of carcinoma of the cervixTate Thigpen
Clinical Obstetrics and Gynecology|February 21, 2012
A rational approach to the management of recurrent or persistent ovarian carcinomaTate Thigpen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Maybe more is betterTate Thigpen
Seminars in Oncology|May 24, 2006
The role of gemcitabine in first-line treatment of advanced ovarian carcinomaTate Thigpen
Seminars in Oncology|February 13, 2002
The role of gemcitabine-based doublets in the management of ovarian carcinomaTate Thigpen
Cancer Investigation|December 3, 2004
First-line therapy for ovarian carcinoma: what's next?Tate Thigpen
The New England Journal of Medicine|December 14, 2004
The if and when of surgical debulking for ovarian carcinomaTate Thigpen
Gynecologic Oncology|December 3, 2014
Contemporary phase III clinical trial endpoints in advanced ovarian cancer: assessing the pros and cons of objective response rate, progression-free survival, and overall survivalJ Tate Thigpen
Lancet (London, England)|December 31, 2002
ICON3 and chemotherapy for ovarian cancerRobert F Ozols, Maurie Markman, J Tate Thigpen
The American Surgeon|August 27, 2004
Management of women who present with T4 breast cancerGalen V Poole, J Tate Thigpen, Ralph B Vance, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cancer Journal (Sudbury, Mass.)|December 24, 2003
The role of chemotherapy in the management of carcinoma of the cervixTate Thigpen
Clinical Obstetrics and Gynecology|February 21, 2012
A rational approach to the management of recurrent or persistent ovarian carcinomaTate Thigpen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Maybe more is betterTate Thigpen
Seminars in Oncology|May 24, 2006
The role of gemcitabine in first-line treatment of advanced ovarian carcinomaTate Thigpen
Seminars in Oncology|February 13, 2002
The role of gemcitabine-based doublets in the management of ovarian carcinomaTate Thigpen
Cancer Investigation|December 3, 2004
First-line therapy for ovarian carcinoma: what's next?Tate Thigpen
The New England Journal of Medicine|December 14, 2004
The if and when of surgical debulking for ovarian carcinomaTate Thigpen
Gynecologic Oncology|December 3, 2014
Contemporary phase III clinical trial endpoints in advanced ovarian cancer: assessing the pros and cons of objective response rate, progression-free survival, and overall survivalJ Tate Thigpen
Lancet (London, England)|December 31, 2002
ICON3 and chemotherapy for ovarian cancerRobert F Ozols, Maurie Markman, J Tate Thigpen
The American Surgeon|August 27, 2004
Management of women who present with T4 breast cancerGalen V Poole, J Tate Thigpen, Ralph B Vance, et al.
Pageof 4